News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Donegan Michael C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 50,000 restricted stock units
@ $0 |
|
| 01/30/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 1,648 shares
@ $5.0796, valued at
$8.4k
Sold 49 shares
@ $5.09, valued at
$249.4
Exercised 2,400 rights
@ $0
Exercised 1,140 rights
@ $0 |
|
| 01/25/2023 |
4
| Donegan Michael C (Prin. Fin. and Acctg. Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 1,302 shares
@ $5.3383, valued at
$7k
Sold 7 shares
@ $5.3101, valued at
$37.2
Exercised 380 restricted stock units
@ $0
Exercised 1,066 restricted stock units
@ $0
Exercised 519 restricted stock units
@ $0
Exercised 2,400 restricted stock units
@ $0 |
|
| 12/09/2022 |
4
| Donegan Michael C (Interim CFO/CAO/VP of Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 910 shares
@ $4.775, valued at
$4.3k
Exercised 2,300 restricted stock units
@ $0
Exercised 380 restricted stock units
@ $0
Exercised 534 restricted stock units
@ $0
Exercised 262 restricted stock units
@ $0 |
|
| 03/31/2022 |
4
| Donegan Michael C (CAO and VP of Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 120,000 rights
@ $0 |
|
| 03/28/2022 |
4
| Donegan Michael C (CAO and VP of Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 120,000 restricted stock units
@ $0 |
|
| 12/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/01/2021 |
4
| Donegan Michael C (CAO and VP of Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 38,954 restricted stock units
@ $0
Disposed of 50,000 options to buy
@ $5.01, valued at
$250.5k
Disposed of 100,000 options to buy
@ $8.92, valued at
$892k
Disposed of 40,000 options to buy
@ $6.83, valued at
$273.2k
Disposed of 100,000 options to buy
@ $5.16, valued at
$516k
|
|
| 07/02/2021 |
4
| Donegan Michael C (CAO and VP Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 160,000 rights
@ $0
Granted 80,000 restricted stock units
@ $0 |
|
| 05/12/2021 |
4
| Donegan Michael C (CAO and VP Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Sold 4,842 shares
@ $1.04, valued at
$5k
Exercised 19,000 restricted stock units
@ $0 |
|
| 11/27/2020 |
4
| Donegan Michael C (Chief Accounting Officer) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 230,000 restricted stock units
@ $0 |
|
| 04/01/2020 |
4
| Donegan Michael C (Vice President Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 57,000 rights
@ $0
Granted 57,000 restricted stock units
@ $0 |
|
| 08/30/2019 |
4
| Donegan Michael C (Vice President Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 120,000 options to buy
@ $2.73, valued at
$327.6k
|
|
| 03/19/2018 |
4
| Donegan Michael C (Vice President Finance) has filed a Form 4 on TherapeuticsMD, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.16, valued at
$516k
|
|
| 03/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|